Siddharth Singh * UCSD Profiles

Siddharth Singh

Title(s)	Assistant Professor Of Clinical, Medicine
School	Health Sciences
Phone	858-246-2352
vCard	Download vCard

Biography

Education and Training

All India Institute of Medical Sciences, New Delhi	MD	2006	Medicine
UCLA and VA Greater Los Angeles Healthcare System	Postdoctoral Scholarship	2008	Membrane Biology
University of Iowa Hospitals and Clinics	Internship	2009	Internal Medicine
University of Iowa Hospitals and Clinics	Residency	2011	Internal Medicine
Mayo Clinic, Rochester	Fellowship	2014	Gastroenterology & Hepatology
Mayo Clinic, Rochester	Advanced Fellowship	2015	Inflammatory Bowel Diseases
Mayo Clinic, Rochester	Master's Degree	2015	Clinical and Translational Science

ORNG Applications

Websites

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Singh S, Picardo S, Seow CH. Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old or Obstetric. Clin Gastroenterol Hepatol. 2019 Nov 08. PMID: 31712084.

View in: PubMed
Singh S. Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils. Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101614. PMID: 31327401.

View in: PubMed
Singh S, Proudfoot JA, Dulai PS, Xu R, Feagan BG, Sandborn WJ, Jairath V. Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials. Clin Gastroenterol Hepatol. 2019 May 17. PMID: 31108227.

View in: PubMed
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2019 Mar 12. PMID: 30876964.

View in: PubMed
Singh S. Evolution of Clinical Trials in Inflammatory Bowel Diseases. Curr Gastroenterol Rep. 2018 Aug 04; 20(9):41. PMID: 30078058.

View in: PubMed
Singh S, Nguyen GC. Management of Crohn's Disease After Surgical Resection. Gastroenterol Clin North Am. 2017 09; 46(3):563-575. PMID: 28838415.

View in: PubMed
Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):27-38.e4. PMID: 28479504.

View in: PubMed
Singh S, Andersen NN, Andersson M, Loftus EV, Jess T. Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1218-1225.e7. PMID: 27913244.

View in: PubMed
Singh S, Heien HC, Sangaralingham LR, Schilz SR, Kappelman MD, Shah ND, Loftus EV. Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2016 08; 14(8):1120-1129.e6. PMID: 27058635.

View in: PubMed
Singh S, Ding NS. Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply. Aliment Pharmacol Ther. 2015 Nov; 42(10):1237. PMID: 26449866.

View in: PubMed
Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct; 149(4):958-70.e12. PMID: 26091937.

View in: PubMed